| Value | ₹450.0 Cr |
|---|---|
| Execution period | 18 months |
BSE filing, NSE: SGFIN. Summary written from the filing by ALFA Finder's alert engine.
SG Finserve Ltd: key numbers
- Share price
- ₹689.00
- Market cap
- ₹4,611 Cr
- Revenue (annual)
- ₹333.4 Cr
- Net profit (annual)
- ₹127.7 Cr
- P/E (TTM)
- 24.6×Sector 19.8×
- Promoter holding
- 56.95%+0.00% QoQ
- FII holding
- 1.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SG Finserve Ltd
All →SG Finserve Acquisition Worth ₹4.65 Cr
SG Finserve Limited is acquiring a 15.50% stake in Successship Technologies Private Limited for ₹4.65 Crore to enhance its in-house AI and digital capabilities.
- Value
- ₹4.65 Cr
SG Finserve Acquisition Worth ₹0.01 Cr
SG Finserve Limited will acquire an equity stake in SG Enterprise Solutions Private Limited for Rs. 0.01 Crore to establish a group shared services model.
- Value
- ₹0.01 Cr
- Execution
- 31-12-2026
SG Finserve Management Change
SG Finserve Limited has appointed Mr. Alok Bhushan as Internal Auditor for a three-month term, following the resignation of Mr. Saurabh Mishra.
SG Finserve Investor Presentation: Key Takeaways
SG Finserve reported record Q2FY27 performance with PAT reaching ₹59 Cr. The company is scaling its supply chain finance ecosystem, with 75% of the loan book now outside the APL Apollo Group.
- Call
- Guides 32% growth
SG Finserve Q2 FY27 Results: Net Profit ₹58.8 Cr, Up 107.0% YoY
SG Finserve Ltd reported revenue from operations of ₹160.9 Cr (+115.4% YoY) and net profit of ₹58.8 Cr (+107.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹58.8 Cr · +107.0% YoY
SG Finserve Board Meeting Date
SG Finserve Limited has scheduled a board meeting on 16 October 2026 to consider and approve its standalone and consolidated financial results for the half-year period.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.